Allison McMahan, Malin Joleby, Gerhard Andersson, Elizabeth J Letourneau, Michael C Seto, Timothy J Luke, Christoffer Rahm
{"title":"An international randomized waitlist-controlled trial of internet-delivered cognitive behavioral therapy for sexual urges toward children.","authors":"Allison McMahan, Malin Joleby, Gerhard Andersson, Elizabeth J Letourneau, Michael C Seto, Timothy J Luke, Christoffer Rahm","doi":"10.1037/ccp0001019","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Test whether Prevent It 2.0, a 9-week, anonymous internet-delivered cognitive behavioral therapy (iCBT) program, reduces the severity of sexual urges and behaviors toward children to prevent acts of child sexual exploitation and abuse.</p><p><strong>Method: </strong>In a randomized 1:1 waitlist-controlled trial with crossover at Karolinska Institutet, Sweden, N = 203 adults (≥18 years; 92.1% men, 0.5% women, 7.4% other; age 18-70, 66.6% aged 21-40; 49.8% Europe, 38.9% North America) were allocated to iCBT (n = 100) or waitlist (n = 103). The preregistered primary outcome was severity of sexual urges toward children (adapted Sexual Symptoms Assessment Scale). Secondary outcomes included weekly time spent observing children for sexual purposes, including use of child sexual abuse material, and severity of accessed material. The study was preregistered on https://ClinicalTrials.gov (ID: NCT05663047; Karolinska Institutet, 2022) and the Open Science Framework (DOI: https://doi.org/10.17605/OSF.IO/Y2DC4; Rahm et al., 2022).</p><p><strong>Results: </strong>iCBT participants reported a significantly greater reduction in sexual urges toward children (-6.41 scale points, 95% confidence interval, CI [-8.26, -4.56]; d = -1.01, 95% CI [-1.30, -0.72]), as well as a significant decrease in time spent observing children for sexual purposes (including use of child sexual abuse material; -1.87 hr weekly, 95% CI [-2.91, -0.82], d = -0.517, 95% CI [-0.806, -0.228]) after 9 weeks compared to the attention-controlled waitlist.</p><p><strong>Conclusions: </strong>Prevent It 2.0 demonstrated efficacy in reducing sexual urges and offending related behaviors toward children, producing clinically significant reductions over 9 weeks, in an anonymous online sample. (PsycInfo Database Record (c) 2026 APA, all rights reserved).</p>","PeriodicalId":15447,"journal":{"name":"Journal of consulting and clinical psychology","volume":"94 7","pages":"425-436"},"PeriodicalIF":6.0000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of consulting and clinical psychology","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1037/ccp0001019","RegionNum":1,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Test whether Prevent It 2.0, a 9-week, anonymous internet-delivered cognitive behavioral therapy (iCBT) program, reduces the severity of sexual urges and behaviors toward children to prevent acts of child sexual exploitation and abuse.
Method: In a randomized 1:1 waitlist-controlled trial with crossover at Karolinska Institutet, Sweden, N = 203 adults (≥18 years; 92.1% men, 0.5% women, 7.4% other; age 18-70, 66.6% aged 21-40; 49.8% Europe, 38.9% North America) were allocated to iCBT (n = 100) or waitlist (n = 103). The preregistered primary outcome was severity of sexual urges toward children (adapted Sexual Symptoms Assessment Scale). Secondary outcomes included weekly time spent observing children for sexual purposes, including use of child sexual abuse material, and severity of accessed material. The study was preregistered on https://ClinicalTrials.gov (ID: NCT05663047; Karolinska Institutet, 2022) and the Open Science Framework (DOI: https://doi.org/10.17605/OSF.IO/Y2DC4; Rahm et al., 2022).
Results: iCBT participants reported a significantly greater reduction in sexual urges toward children (-6.41 scale points, 95% confidence interval, CI [-8.26, -4.56]; d = -1.01, 95% CI [-1.30, -0.72]), as well as a significant decrease in time spent observing children for sexual purposes (including use of child sexual abuse material; -1.87 hr weekly, 95% CI [-2.91, -0.82], d = -0.517, 95% CI [-0.806, -0.228]) after 9 weeks compared to the attention-controlled waitlist.
Conclusions: Prevent It 2.0 demonstrated efficacy in reducing sexual urges and offending related behaviors toward children, producing clinically significant reductions over 9 weeks, in an anonymous online sample. (PsycInfo Database Record (c) 2026 APA, all rights reserved).
期刊介绍:
The Journal of Consulting and Clinical Psychology® (JCCP) publishes original contributions on the following topics: the development, validity, and use of techniques of diagnosis and treatment of disordered behaviorstudies of a variety of populations that have clinical interest, including but not limited to medical patients, ethnic minorities, persons with serious mental illness, and community samplesstudies that have a cross-cultural or demographic focus and are of interest for treating behavior disordersstudies of personality and of its assessment and development where these have a clear bearing on problems of clinical dysfunction and treatmentstudies of gender, ethnicity, or sexual orientation that have a clear bearing on diagnosis, assessment, and treatmentstudies of psychosocial aspects of health behaviors. Studies that focus on populations that fall anywhere within the lifespan are considered. JCCP welcomes submissions on treatment and prevention in all areas of clinical and clinical–health psychology and especially on topics that appeal to a broad clinical–scientist and practitioner audience. JCCP encourages the submission of theory–based interventions, studies that investigate mechanisms of change, and studies of the effectiveness of treatments in real-world settings. JCCP recommends that authors of clinical trials pre-register their studies with an appropriate clinical trial registry (e.g., ClinicalTrials.gov, ClinicalTrialsRegister.eu) though both registered and unregistered trials will continue to be considered at this time.